Graves' orbitopathy: Current imaging procedures

Swiss Medical Weekly

Volumn 139, Issue 43-44, 2009, Pages 618-623

  Kirsch, Eberhard ^a,b   Hammer, Beat ^b   Von Arx, Georg ^c  

^a KLINIK HIRSLANDEN   (Switzerland)

^b Hirslanden Medical Center   (Switzerland)

^c Interdisciplinary Centre for Graves' Orbitopathy   (Switzerland)

Author keywords

Computed tomography; Graves' orbitopathy; Magnetic resonance imaging; TIRM sequences

Indexed keywords

CONTRAST MEDIUM; GADOLINIUM; IMMUNOMODULATING AGENT;

A SCAN; B SCAN; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DECOMPRESSION SURGERY; DIFFERENTIAL DIAGNOSIS; EDEMA; ENDOCRINE OPHTHALMOPATHY; EXOPHTHALMOS; EXTRAOCULAR MUSCLE; FIBROSIS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATION; MYOSITIS; NERVE COMPRESSION; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIC NERVE; ORBIT INFLAMMATION; REVIEW; TREATMENT RESPONSE;

EID: 70449369673     PISSN: 14247860     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (16)

1. Wiersinga WM, Smit T, van der Gaag R, Mourits M, Koornneef L. Clinical presentation of Graves' ophthalmopathy. Ophthalmic Res. 1989;21:73-82.
2. Mourits MP. Diagnosis and Differential Diagnosis of Graves' Orbitopathy. In: Wiersinga WM, Kahaly GJ editors: Graves' Orbitopathy: A Multidisciplinary Approach. Basel, Karger, 2007, pp 66-77.
3. Bartalena L, Baldeschi L, Dickinson AJ, Eckstein A, Kendall- Taylor P, Marcocci C, et al. Consensus Statement of the European Group on Graves' Orbitopathy (EUGOGO) on Management of Graves' Orbitopathy. Thyroid. 2008;18:333-346
4. European Group on Graves' Orbitopathy (EUGOGO), Wiersinga WM, Perros P, Kahaly GJ, Mourits MP, Baldeschi L, Boboridis K, et al. Clinical assessment of patients with Graves' orbitopathy: the European Group on Graves' Orbitopathy recommendations to generalists, specialists and clinical researchers. Eur J Endocrinol. 2006;155:387-389
5. Werner SC. Modification of the classification of eye changes of Graves' disease. Am J Ophthalmol. 1977;83:725-727 (Pubitemid 8136099)
6. Kahaly GJ. Imaging in thyroid-associate orbitopathy. Eur J Endo. 2001;145:107-118
7. Ott M, Breiter N, Albrecht CF, Pradier O, Hess CF, Schmidberger H. Can contrast enhanced MRI predict the response of Graves' ophthalmopathy to orbital radiotherapy? Br J Radiol. 2002;75:514-517
8. Cakirer S, Cakirer D, Basak M, Durmaz S, Altuntas Y, Yigit U. Evaluation of extra-ocular muscles in the edematous phase of Graves' ophthalmopathy on contrast-enhanced fat-suppressed magnetic resonance imaging. Comput Assist Tomogr. 2004;28: 80-86 (Pubitemid 38057859)
9. Mourits MP. Diagnosis and Differential Diagnosis of Graves' Orbitopathy. In Wiersinga W.M., Kahaly GJ Graves' Orbitopathy: A Multidisciplinary Approach. Karger, Basel, 2007; pp: 66-77.
10. Mayer EJ, Fox DL, Herdman G, Hsuan J, Kabala J, Goddard P, et al. Signal intensity, clinical activity and cross-sectional areas on MRI scans in thyroid eye disease. Eur J Radiol. 2005;56:20-24 (Pubitemid 41316481)
11. Yokoyama N, Nagataki S, Uetani M, Ashizawa K, Eguchi K. Role of magnetic resonance imaging in the assessment of disease activity in thyroid-associated ophthalmopathy. Thyroid. 2002;12:223-227 (Pubitemid 34259803)
12. Szucs-Farkas Z, Toth J, Balazs E, Galuska L, Burman KD, Karanyi Z, Leovey A, Nagy EV. Using morphologic parameters of extra-ocular muscles for diagnosis and follow-up of Graves' ophthalmopathy: diameters, areas, or volumes? Am J Roentgenol. 2002;179:1005-1010
13. Kahaly GJ. Recent developments in Graves' ophthalmopathy imaging. J Endocrinol Invest. 2004;27:254-258 Review.
14. Pauleit D, Schüller H, Textor J, Leutner C, Keller E, Sommer T, et al. MR relaxation time measurements with and without selective fat suppression (SPIR) in endocrine orbitopathy. Rofo. 1997;167:557-564 (Pubitemid 28044626)
15. Ossoinig KC. The role of standardized echography in Graves' disease. Acta Ophthalmol Suppl. 1992;204:81.
16. Prummel MF, Suttorp-Schulten MS, Wiersinga WM, Verbeek AM, Mourits MP, Koornneef L. A New ultrasonographic method to detect disease activity and predict response to immunosuppressive treatment in Graves' ophthalmopathy. Ophthalmology. 1993;100:556-561 (Pubitemid 23120706)